10x Genomics, Inc. Restructuring Charges
10x Genomics, Inc. (TXG) reported Restructuring Charges of $10.59 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-02-13
- 10x Genomics, Inc. restructuring charges for the quarter ending 2025-12-31 was $4.57M.
- 10x Genomics, Inc. restructuring charges for the quarter ending 2025-09-30 was $6.00M.
- 10x Genomics, Inc. restructuring charges for the quarter ending 2025-06-30 was $6.02M.
- 10x Genomics, Inc. restructuring charges for the quarter ending 2025-03-31 was -$6.00M.
- 10x Genomics, Inc. restructuring charges for fiscal 2025 was $10.59M, a 3988.80% increase from fiscal 2024.
- 10x Genomics, Inc. restructuring charges for fiscal 2024 was $259.00K, a 89.56% decline from fiscal 2023.
- 10x Genomics, Inc. restructuring charges for fiscal 2023 was $2.48M, a 41.15% decline from fiscal 2022.
- 10x Genomics, Inc. restructuring charges for fiscal 2022 was $4.22M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $10.57M derived: sum of 2 quarters · filed 2026-02-13 | $16.59M derived: sum of 3 quarters · filed 2026-02-13 | $10.59M 10-K · filed 2026-02-13 |
| 2025-09-30 | $6.00M 10-Q · filed 2025-11-07 | $12.02M derived: sum of 2 quarters · filed 2025-11-07 | $6.02M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $6.02M 10-Q · filed 2025-08-08 | $6.02M 10-Q · filed 2025-08-08 | ||
| 2025-03-31 | -$6.00M derived: 10-K 12 month − 3 quarters · filed 2026-02-13 | |||
| 2024-12-31 | $259.00K 10-K · filed 2026-02-13 | |||
| 2023-12-31 | $2.48M 10-K · filed 2026-02-13 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $4.22M 10-K · filed 2025-02-13 | ||
| 2022-09-30 | $4.22M 10-Q · filed 2022-11-03 |